How to Buy Halozyme Therapeutics Stock
Halozyme Therapeutics Inc
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally.
Halozyme Therapeutics stock last closed at $61.42, up 0.99% from the previous day, and has increased 61.21% in one year. It has overperformed other stocks in the Biotechnology industry by 1.38 percentage points. Halozyme Therapeutics stock is currently +57.97% from its 52-week low of $38.88, and -6.94% from its 52-week high of $66.00.
There are currently 123.15M HALO shares outstanding. The market cap of HALO is $7.56B. In the last 24 hours, 1.37M HALO shares were traded.
How to Buy Halozyme Therapeutics Stock
Not sure how to invest in Halozyme Therapeutics stock? Here's how.
- Choose where to buy Halozyme Therapeutics stock: You need to pick a stock brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you choose where to buy Halozyme Therapeutics stock.
- Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Put funds into your investment account: Pick your method of payment and add your information.
- Analyze Halozyme Therapeutics stock: The Halozyme Therapeutics ticker symbol is HALO. Is Halozyme Therapeutics stock a good investment? Should you buy shares of HALO? How do HALO's underlying business fundamentals look? Do top analysts think Halozyme Therapeutics is a good buy? Why has HALO's stock price moved recently? (Hint: Our stock research website can help you understand if HALO is a good stock to buy).
- Place your HALO buy order: Decide if you will purchase HALO shares at the current market price or use a limit order to purchase HALO stock at a particular price.
- Get the latest news on your investment in HALO: Create a watchlist to monitor your investment in Halozyme Therapeutics shares.
Step 1: Choose where to buy Halozyme Therapeutics stock
You need a brokerage account to access the NASDAQ market and buy HALO stock.
Our recommended brokerage: eToro
Based on our analysis, eToro is the best place to buy stocks. Here's why:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to world financial markets: From Tech to Utilities, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro boasts a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've picked the best brokerage, the next step is to fill out some personal information so you are able to buy HALO today.
How to Create a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to start your new brokerage account.
- Submit your data by clicking the "Create Account" button. Get started with eToro today
Step 3: Put funds into your investment account
Now that you've filled out your info on app for stock, your next step is to transfer the money for your investment:
Check out this video walkthrough to see the process of transferring money into your brokerage account.
Step 4: Analyze Halozyme Therapeutics stock
After you have chosen the best place to buy Halozyme Therapeutics stock, it's crucial to evaluate their stock before you buy, so you actually comprehend the risk and opportunity.
Halozyme Therapeutics Metrics
HALO Due Diligence Score
WallStreetZen was created to help part-time investors perform more in-depth fundamental analysis quickly.
You can view all of the due diligence checks on HALO's stock page.
What is the fair value of HALO stock?
Investors use many financial metrics, analyses, models, and charts to gauge HALO's intrinsic value.
Using relative valuations methods:
- HALO could be undervalued based on its P/E ratio of 17.55x, relative to Biotechnology industry P/E ratio of -162.28x
- HALO may be overvalued based on its P/B ratio of 20.79x, relative to Biotechnology industry P/B ratio of 4.45x
- HALO may be undervalued based on its PEG ratio of 0.58x
You can do additional valuation analysis on HALO's stock here.
HALO Financials at a glance
Signs that HALO is financially healthy:
- Total HALO debt is lower than 5 years ago, relative to shareholder equity.
- HALO profit margin has gone up from 34% to 43.7% in the past year.
- HALO's operating cash flow of $479.06M allows it to safely service it's debt of $1.51B.
- There are more short-term assets than short-term liabilities on the HALO balance sheet.
- HALO earnings of $575.23M is not sufficient to cover its interest payments.
Signs that HALO is not financially healthy:
- There are more long-term liabilities than short-term assets on the HALO balance sheet.
- HALO has a relatively high debt to equity ratio of 4.67.
Do Wall Street analysts think it's a good time to buy Halozyme Therapeutics stock
Out of 6 Equities analysts who monitor HALO, the consensus analyst rating on Halozyme Therapeutics is a Buy
It's important to note that analyst forecasts are not stock recommendations, nor are they investment advice.
Latest HALO Analyst Recommendations
Jason Butler, a top 20% analyst from JMP Securities maintains HALO with a buy rating and raises their HALO price target from $72.00 to $73.00, on Nov 1, 2024.
You can dig deeper into what analysts are projecting on the Halozyme Therapeutics stock forecast page.
HALO Technicals
Is HALO Making Money?
Last year, HALO earnings were $444.09M. Over the past 4 year, HALO's earnings have grown by 38.54% per year. This was faster than the Biotechnology industry average of 10.4%.
Last year, HALO revenue was $1.02B. Over the past 5 year, HALO's revenue has increased by 38.95% per year. This was slower than the Biotechnology industry average of 45.66%.
Find out more about HALO's earnings and revenue performance here.
Who is buying/selling HALO?
In the past year, insiders at HALO have sold more shares than they have bought.
Jeffrey William Henderson, Director of HALO, was the latest HALO insider to sell. They sold $259,268.09 worth of HALO shares on Apr 28, 2025.
Learn more about who owns HALO stock here.
Can I rely on HALO as an income stream?
No, Halozyme Therapeutics doesn't provide an income stream by paying out dividends.
What others are saying about HALO
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Place your HALO buy order
There are two primary types of orders:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are usually sufficient. - Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at a particular price, use a limit order.
Hit the Open button and eToro will place the order.
If you want additional help with buying stocks on eToro, watch the helpful video below:
Step 6: Get the latest news on your investment in HALO
Now that you own some HALO stock, you'll want to keep up with your new shares.
Put HALO on a watchlist to get notified of the latest news about your HALO stock.
HALO Feed
How to Buy Stock in Halozyme Therapeutics
To reiterate, here are the 6 steps to buy Halozyme Therapeutics stock:
- Choose where to buy Halozyme Therapeutics stock
- Sign up for your brokerage account
- Put funds into your investment account
- Analyze Halozyme Therapeutics stock
- Place your HALO buy order
- Get the latest news on your investment in HALO
If you are looking for a brokerage account, eToro is our recommended option.
Get Started with eToro TodayIf you want to monitor your new investment in Halozyme Therapeutics, get started below.
Other Articles You Might Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.